Medicare GLP-1 Bridge vs TrumpRx: Which Is Cheaper in 2026?

Medicare GLP-1 Bridge vs TrumpRx: Which Is Cheaper?

The Bridge is far cheaper for people who qualify. It costs $50 per monthly fill -- $600 over 12 fills -- no matter the dose. Current cash prices for the same drugs, through TrumpRx or the drugmakers, run about $149 to $699 per month depending on the drug, dose, and refill timing. The gap is the whole story.

Here's what 12 fills cost under each path

Prices verified July 2026 against drugmaker and CMS sources.

Read the fine print. A Bridge "month" is a 28- or 30-day supply, so 12 fills is roughly a year. Cash figures multiply today's listed prices -- but most people move to higher maintenance doses over time. Two prices carry deadlines: Wegovy's 4 mg pill is $149 only through August 31, 2026 (then $199), and eligible new patients pay $199 for their first two Wegovy pen fills through December 31, 2026 (then $349). Higher-dose Zepbound holds its $449 price only if you refill within 45 days -- miss that window and it can jump to $499-$699.

Even with all that, the pattern is hard to miss. Qualifying for the Bridge saves roughly $1,188 to $4,788 over 12 fills -- and if you're on higher-dose Zepbound and keep missing the refill window, the gap can reach about $7,788. Same FDA-approved brand. That's not a coupon. For a lot of people, that's the difference between doing this and not.

Ready to see if the $50 lane is open to you? Check your eligibility on Medicare.gov's Bridge tool and bring it to your prescriber.

What's the actual difference between the Bridge and TrumpRx?

The Medicare GLP-1 Bridge is a temporary Medicare program that lets your pharmacy fill a covered weight-loss prescription for a flat $50. TrumpRx is not insurance, not a Medicare benefit, and not a pharmacy -- it's a federal website that either hands you a coupon to use at a pharmacy or sends you to the drugmaker to buy at a cash price. They work nothing alike, and you can't combine them on one fill.

They get confused because both are new and both are federal. But the differences matter.

What the Medicare GLP-1 Bridge is

The Bridge is a short-term test program (a "demonstration") run by the Centers for Medicare & Medicaid Services -- CMS, the agency that runs Medicare. It launched July 1, 2026, and runs through December 31, 2027. It sits outside your regular Part D drug benefit, so your drug plan doesn't have to opt in and carries none of the cost. One company, Humana, handles the approvals and pays pharmacies on Medicare's behalf. You pay $50 at the counter. Weight management only.

What TrumpRx is -- and isn't

TrumpRx (TrumpRx.gov) launched February 5, 2026. It's a price-and-savings site. Depending on the drug, it either gives you a coupon to present at a retail pharmacy (that's how Wegovy works right now) or routes you into the drugmaker's own pharmacy like LillyDirect (Zepbound and Foundayo). It does not sell drugs directly, does not prescribe, and does not create Medicare coverage. One detail almost nobody mentions: the price you get is usually the drugmaker's own cash offer -- the same one you could find on NovoCare or LillyDirect. The TrumpRx label doesn't stack an extra discount on top.

Do you qualify for the Medicare GLP-1 Bridge?

To qualify, you generally must be 18 or older, enrolled in an eligible Medicare Part D plan, using a covered drug only for weight management, and meet one of three BMI-and-health rules. A clinician writes the prescription, and a prior authorization is submitted for the Bridge. Confirm your exact case on Medicare.gov, because the health-condition list changes by BMI level.

Eligibility has two layers. Miss either and the Bridge is closed to you.

Layer 1: Your Medicare plan

You must have Medicare drug coverage in 2026 through one of these:

• A standalone Part D prescription drug plan (a "PDP"), or
• A Medicare Advantage plan that includes drug coverage (an "MA-PD" -- HMO, HMO-POS, or PPO)

Certain other Part D plan types also count, including some Special Needs Plans, employer or union group plans, and the LI NET program. But Original Medicare alone, with no drug plan, does not get you in.

Layer 2: Your weight and health

You qualify if any one of these fits (this is the official list from Medicare.gov):

Who should use regular Part D instead

The Bridge is for weight. If your GLP-1 is prescribed for a condition your Part D plan already covers, that's your lane. This includes type 2 diabetes, moderate-to-severe sleep apnea, MASH (a liver condition with scarring), or lowering the risk of heart attack and stroke in people with known heart disease. If any of those is your reason, the prescription goes through your normal drug plan -- even if the drug isn't on your plan's list yet, your usual coverage-exception and appeal rights still apply. Having heart disease by itself doesn't block the Bridge, though, if the prescription is only for weight. Ask your prescriber which lane fits your situation.

Want to know if you clear both layers before you call the doctor? Get your personalized read with Find My GLP-1 Path -- then bring our question list to your appointment.

How does Medicare GLP-1 Bridge prior authorization work?

The Bridge uses a pharmacy-first process, and it does not go through your Part D plan. Your prescriber sends the prescription to the pharmacy; the pharmacy runs a Bridge claim, which triggers the approval request to your prescriber; your prescriber confirms you meet the rules; and Humana decides. Once approved, you pay $50 at pickup. There is no formal appeals process under the Bridge.

Step by step, here's the actual sequence:

1. 1Your prescriber sends the prescription to your pharmacy.
2. 2The pharmacy submits a Bridge claim (to a dedicated Bridge routing code, not your Part D plan).
3. 3That claim triggers a prior-authorization request back to your prescriber, usually within a day or two.
4. 4Your prescriber attests that you meet the BMI-and-health rules and that the drug is for weight management.
5. 5Humana -- the Bridge's processor -- sends its decision, typically within 72 hours of submission. You get the decision by mail; your prescriber gets it electronically or by fax.
6. 6If approved, the pharmacy re-runs the claim and you pay $50.

For the complete walkthrough -- who submits what, what to do if it stalls, and the exact phone numbers -- see our Medicare Bridge prior-authorization guide.

Which drugs does the Bridge cover?

The Bridge covers three FDA-approved weight-management drugs in specific forms. Form matters -- the wrong form is not a Bridge claim, even if the drug itself is listed.

Does the Bridge or TrumpRx count toward my Part D deductible or out-of-pocket max?

No -- neither one does. The Bridge's $50 copay sits outside your Part D benefit, so it doesn't count toward your deductible or the $2,100 yearly out-of-pocket cap, and Extra Help can't reduce it. TrumpRx cash purchases are outside Medicare entirely, so they don't count either.

For most people this doesn't change the answer -- saving thousands on the drug still beats the credit you'd lose toward a cap. But here's when it matters: if other expensive drugs are already pushing you toward that $2,100 cap this year, every dollar that counts toward the cap has extra value, because once you hit it your other covered drugs cost you nothing more for the year. Bridge and TrumpRx dollars don't move you toward that finish line. Covered Part D spending does.

So if you're near your cap, do a quick plan-specific comparison: ask your Part D plan whether it covers a GLP-1 for a condition you actually have, and weigh that against the Bridge's flat $50. If you're nowhere near the cap, this is a footnote and the Bridge is almost certainly your cheapest path.

Can you use TrumpRx if you're on Medicare?

Yes -- you can use a TrumpRx cash offer while on Medicare, but only as a true cash purchase. You can't run it through Medicare, count it toward your deductible or cap, or ask your plan to pay you back. And you can't combine it with the Bridge on the same fill.

When should you use TrumpRx instead of the Bridge?

Use TrumpRx (or another cash path) when the Bridge doesn't apply -- you lack Part D drug coverage, you don't meet the health rules, you need a form the Bridge excludes, or you choose to pay cash. Don't give up a $50 Bridge approval because a cash checkout looks simpler; that trade costs thousands.

If you don't qualify and need a prescriber

If the Bridge is closed to you and you want brand-name treatment, you have two honest cash routes:

1. 1.Go through the drugmaker -- LillyDirect or NovoCare (or via TrumpRx, which sends you there). This is the route if you already have a prescriber and want to avoid a separate membership fee.
2. 2.Use a telehealth service that evaluates you and, if appropriate, prescribes -- then a partner pharmacy ships the medicine. It adds a membership cost, but handles the visit and prescription for you.

What are the biggest catches with the Bridge?

The Bridge is cheap but temporary, narrow, and separate from normal Part D. The $50 doesn't build toward your deductible or cap, Extra Help can't reduce it, it covers only specific drugs and forms, there's no appeals process, and it ends December 31, 2027 with no guaranteed replacement.

None of these should scare off the right person. But you deserve to see them plainly.

• •It's temporary. The program ends December 31, 2027. Don't assume $50 access continues into 2028.
• •No appeals. If you're denied, there's no Part D-style appeal for the Bridge -- your prescriber corrects and resubmits.
• •Extra Help won't lower it. For lower-income members, this is real: the low-income subsidy that cuts other drug costs does not touch the $50.
• •It doesn't count toward your cap or deductible. Covered above -- matters most if you're near your $2,100 cap from other drugs.
• •Form matters. Zepbound must be the KwikPen; a vial prescription won't fill under the Bridge.

Where each catch sends you: near your cap → ask about a regular Part D path; don't meet the rules → the cash comparison above; prescribed a Zepbound vial → LillyDirect; can't manage the $50 → call 1-800-MEDICARE or your State Health Insurance Assistance Program (SHIP) about assistance before paying cash anywhere.

What happens if you switch GLP-1 drugs?

One Bridge approval covers your refills and dose changes through December 31, 2027. But switching to a different covered drug -- say, from Wegovy to Zepbound -- starts a new approval. A dose change within the same drug is fine; a drug change is not automatic.

So if your prescriber raises your Wegovy dose, you're still covered under the same approval. If you move from Wegovy to Foundayo or Zepbound, your prescriber submits a fresh prior authorization for the new drug, and Humana decides -- typically within 72 hours of submission.

What happens when the Bridge ends in 2027?

The current Bridge approvals end December 31, 2027. No replacement Medicare weight-loss benefit is guaranteed to follow. Check CMS guidance well before your last approved fill instead of assuming the same $50 access continues in 2028.

The follow-on program -- the BALANCE Model -- will not launch in Medicare Part D in 2027; CMS said in May 2026 that the Part D piece would be delayed, and extended the Bridge through 2027 instead. Permanent Medicare coverage of weight-loss drugs would take an act of Congress. That's not a reason to skip the Bridge now -- it's a real, meaningful window of affordable access. It's a reason to plan ahead:

• Recheck CMS updates about six months before the end date.
• Recheck after any major Medicare announcement.
• Talk continuity through with your prescriber early.
• Don't stop or change treatment because of a cost projection alone -- that's a medical decision.

The December 31, 2027 deadline is genuine. We won't dress it up, and we won't bury it either.

Your next step, in three moves

First, find your lane: is this for weight, or for a condition your plan already covers? Second, pin down the exact drug and form. Third, ask your prescriber to send it down the right path. Here's a script you can hand your doctor or pharmacy.

How we compared these two paths

We compared the Bridge and TrumpRx using current CMS and Medicare rules, the drugmakers' own cash prices, form-by-form eligibility, and plain arithmetic. We score on clinical legitimacy, care quality, transparency, access, and cost -- the five pillars of the RX Index Score. We don't rank which medicine works better or decide what's right for you; that's between you and your clinician.

Primary sources we checked (July 17, 2026): CMS Medicare GLP-1 Bridge program, provider, pharmacy, and Part D plan pages; the Medicare.gov "Weight loss drugs" page and the official Bridge fact sheet; NovoCare (current Wegovy self-pay prices and terms); LillyDirect (current Zepbound self-pay prices and terms); and TrumpRx (current Wegovy offer and coupon mechanism). Policy analyses from KFF and NPR provided context.

Who made this and why: The RX Index built this comparison by reading the primary Medicare and CMS rules and the drugmakers' current prices, then organizing them into a form-by-form comparison. We built it because too many Medicare members are being asked to compare a temporary $50 government program against cash offers that work completely differently -- and the honest side-by-side belongs in one place. This is a payment-and-eligibility comparison, not medical advice.

Frequently Asked Questions